These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33970740)

  • 1. Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art.
    Lang SA; Bednarsch J; Joechle K; Amygdalos I; Czigany Z; Heij L; Ulmer TF; Neumann UP
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):497-510. PubMed ID: 33970740
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating Biomarkers for Cholangiocarcinoma.
    Loosen SH; Vucur M; Trautwein C; Roderburg C; Luedde T
    Dig Dis; 2018; 36(4):281-288. PubMed ID: 29807369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
    Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
    J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
    Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
    J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring.
    Wen N; Peng D; Xiong X; Liu G; Nie G; Wang Y; Xu J; Wang S; Yang S; Tian Y; Li B; Lu J; Cheng N
    Signal Transduct Target Ther; 2024 May; 9(1):107. PubMed ID: 38697972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
    Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
    Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current omics-based biomarkers for cholangiocarcinoma.
    Intuyod K; Armartmuntree N; Jusakul A; Sakonsinsiri C; Thanan R; Pinlaor S
    Expert Rev Mol Diagn; 2019 Nov; 19(11):997-1005. PubMed ID: 31566016
    [No Abstract]   [Full Text] [Related]  

  • 9. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
    Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
    Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice.
    Saengboonmee C; Obchoei S; Sawanyawisuth K; Wongkham S
    Expert Rev Anticancer Ther; 2023 May; 23(5):517-530. PubMed ID: 37052887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
    Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
    J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of microRNAs in Cholangiocarcinoma.
    Shi T; Morishita A; Kobara H; Masaki T
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.
    Thanan R; Kaewlert W; Sakonsinsiri C; Chaiprasert T; Armartmuntree N; Muengsaen D; Techasen A; Klanrit P; Lert-Itthiporn W; Pinlaor S; Pairojkul C
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32151057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
    Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
    Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic biomarkers in cholangiocarcinoma.
    Macias RIR; Kornek M; Rodrigues PM; Paiva NA; Castro RE; Urban S; Pereira SP; Cadamuro M; Rupp C; Loosen SH; Luedde T; Banales JM
    Liver Int; 2019 May; 39 Suppl 1():108-122. PubMed ID: 30843325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
    Puik JR; Meijer LL; Le Large TY; Prado MM; Frampton AE; Kazemier G; Giovannetti E
    Pharmacogenomics; 2017 Sep; 18(14):1343-1358. PubMed ID: 28832247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
    Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
    World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.